M Ferreira, MW Redman, KL Reckamp - Journal of Thoracic Oncology, 2023 - jto.org
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced NSCLC.
1 Despite improvements in survival, most will develop tumor resistance, and approaches to …